Bildkälla: Stockfoto

Biovica Commercial Update: A US and European launch within 12 months - Redeye

Biovica recently hosted a post-FDA approval commercial update for DiviTum on the 18th of August. The company is on track for a US launch in early 2023.

Biovica recently hosted a post-FDA approval commercial update for DiviTum on the 18th of August. The company is on track for a US launch in early 2023.
Börsvärldens nyhetsbrev
ANNONSER